Who is sponsoring NCT04723433?

NCT04723433 is sponsored by Stanford University.

What drugs are being tested in NCT04723433?

Interventions in NCT04723433: Oxygen gas -Conservative, Oxygen gas -Liberal.

What condition does NCT04723433 study?

NCT04723433 studies Ventilatory Depression, Postoperative Respiratory Complication.

Is NCT04723433 still recruiting?

NCT04723433 is currently completed. Last updated 14 September 2021.

Last reviewed 2021-09-14 · How we verify

NCT04723433

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Recovery of Ventilation After Anesthesia for Laparoscopic Nephrectomy

Completed NA Last updated 14 September 2021

What this trial tests

NA trial testing Oxygen gas -Conservative in Ventilatory Depression in 20 participants. Completed in 15 June 2021.

Timeline

15 February 2021

Primary endpoint
15 June 2021

15 June 2021

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	20
Start date	15 February 2021
Primary completion	15 June 2021
Estimated completion	15 June 2021
Sites	1 location across United States

Drugs / interventions tested

Oxygen gas -Conservative
Oxygen gas -Liberal

Conditions studied

Ventilatory Depression — all drugs for Ventilatory Depression →
Postoperative Respiratory Complication — all drugs for Postoperative Respiratory Complication →

Sponsor

Stanford University

Who can join

Adults 18 to 70, any sex, with Ventilatory Depression or Postoperative Respiratory Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this randomized, controlled feasibility investigation is to characterize pharmacologically induced ventilatory depression after anesthesia and examine how is affected by the amount of supplemental oxygen patients are receiving in the immediate postoperative period.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The effect of hyperoxia on ventilation during recovery from general anesthesia: A randomized pilot study for a parallel randomized controlled trial.
Doufas AG, Tian L, Kutscher S, Finnsson E, et al · · 2022 · cited 3× · PMID 36265267 · DOI 10.1016/j.jclinane.2022.110982

Verify or expand the search:

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04723433 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 14 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04723433.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing